Low dose intradermal vaccination is superior to high dose intramuscular vaccination for hepatitis B in unresponsive hemodialysis patients

Renal Failure

Volumn 29, Issue 3, 2007, Pages 285-288

  Micozkadioglu, Hasan ^a,b   Zumrutdal, Aysegul ^a   Torun, Dilek ^a   Sezer, Siren ^a   Ozdemir, Fatma Nurhan ^a   Haberal, Mehmet ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b Baskent Universitesi Adana Hastanesi   (Turkey)

Author keywords

Hemodialysis; Hepatitis B; Unresponsiveness

Indexed keywords

HEPATITIS B VACCINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS B; HUMAN; KIDNEY FAILURE; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; STATISTICAL SIGNIFICANCE;

ADULT; AGED; BIOLOGICAL MARKERS; COST-BENEFIT ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RESEARCH DESIGN; TREATMENT OUTCOME; TURKEY; VACCINATION;

EID: 34248531657     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220601166263     Document Type: Article

References (16)

1. Tong NK, Beran J, Kee SA, Miguel JL, Sanchez C, Bayas JM, et al. Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients. Kidney Int. 2005;68(5):2298-2303.
2. Liu YL, Kao MT, Huang CC. A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis. Vaccine 2005;23:3957-3960.
3. Ozdemir FN, Micozkadioglu H, Arat Z, Turan M, Gulmus S, Haberal M. The importance of A3 allele in response to hepatitis B vaccine in end-stage renal disease patients. Transplant Proc. 2004;36(9):2615-2617.
4. Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, Hill AV. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med. 1995;332(16):1065-1069.
5. Sezer S, Ozdemir FN, Guz G, Arat Z, Colak T, Sengul S, et al. Factors influencing response to hepatitis B virus vaccination in hemodialysis patients. Transplant Proc. 2000;32(3):607-608.
6. Caillat-Zucman S, Gimenez JJ, Wambergue F, Albouze G, Lebkiri B, Naret C, et al. Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen. Kidney Int. 1998;53(6):1626-1630.
7. McNulty CA, Bowen JK, Williams AJ. Hepatitis B vaccination in predialysis chronic renal failure patients a comparison of two vaccination schedules. Vaccine 2005;23(32):4142-4147.
8. Chau KF, Cheng YL, Tsang DN, Choi KS, Wong KM, Chak WL, et al. Efficacy and side effects of intradermal hepatitis B vaccination in CAPD patients: a comparison with the intramuscular vaccination. Am J Kidney Dis. 2004;43(5): 910-917.
9. Propst T, Propst A, Lhotta K, Vogel W, Konig P. Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination. Am J Kidney Dis. 1998;32(6):1041-1045.
10. Verkade MA, van de Wetering J, Klepper M, Vaessen LM, Weimar W, Betjes MG. Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients. Kidney Int. 2004;66(2):614-621.
11. Roozbeh J, Moini M, Lankarani KB, Sagheb MM, Shahpoori S, Bastani B. Low dose intradermal versus high dose intramuscular hepatitis B vaccination in patients on chronic hemodialysis. ASAIO J. 2005;51(3):242-245.
12. Argani H, Akhtari E. Levamizol enhances immune responsiveness of intradermal and intramuscular hepatitis B vaccination in hemodialysis patients. J Immune Based Ther Vaccines. 2006;4(1):3.
13. Sonmez E, Sonmez AS, Bayindir Y, Coskun D, Ariturk S. Antihepatitis B response to hepatitis B vaccine administered simultaneously with tetanus toxoid in nonresponder individuals. Vaccine 2002;21(3-4):243-246.
14. DaRoza G, Loewen A, Djurdjev O, Love J, Kempston C, Burnett S, et al. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better. Am J Kidney Dis. 2003;42(6):1184-1192.
15. Saab S, Weston SR, Ly D, Brezina M, Yee HF Jr, Han SH, Gitnick G. Comparison of the cost and effectiveness of two strategies for maintaining hepatitis B immunity in hemodialysis patients. Vaccine 2002;20(25-26):3230-3235.
16. Fabrizi F, Andrulli S, Bacchini G, Corti M, Locatelli F. Intradermal versus intramuscular hepatitis B re-vaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation. Nephrol Dial Transplant. 1997;12(6):1204-1211.